94 related articles for article (PubMed ID: 11190485)
1. Quality control of radiolabeled monoclonal antibodies.
Khazaeli MB
Cancer Biother Radiopharm; 2000 Dec; 15(6):529-30. PubMed ID: 11190485
[No Abstract] [Full Text] [Related]
2. [Monoclonal antibodies. An approach to diagnosis and treatment of micrometastases].
Bier H
HNO; 1994 May; 42(5):255-6. PubMed ID: 8050912
[No Abstract] [Full Text] [Related]
3. Exploration of novel strategies to enhance monoclonal antibodies targeting.
Khawli LA; Epstein AL
Q J Nucl Med; 1997 Mar; 41(1):25-35. PubMed ID: 9195850
[TBL] [Abstract][Full Text] [Related]
4. Radioimmunodetection and radioimmunotherapy of breast cancer.
Riva P; Franceschi G; Gentile R; Riva N; Casi M
Tumori; 1997; 83(2):552-7. PubMed ID: 9226019
[No Abstract] [Full Text] [Related]
5. Targeting of metastatic renal cell carcinoma with the chimeric monoclonal antibody G250 labeled with (131)I or (111)In: an intrapatient comparison.
Brouwers AH; Buijs WC; Oosterwijk E; Boerman OC; Mala C; De Mulder PH; Corstens FH; Mulders PF; Oyen WJ
Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3953S-60S. PubMed ID: 14506194
[TBL] [Abstract][Full Text] [Related]
6. The preparation of radiolabeled monoclonal antibodies for human use.
Tran L; Beijnen JH; Huitema AD
Hum Antibodies; 2009; 18(4):145-56. PubMed ID: 19996529
[TBL] [Abstract][Full Text] [Related]
7. Radioimmunodetection and radioimmunotherapy of head and neck cancer.
Börjesson PK; Postema EJ; de Bree R; Roos JC; Leemans CR; Kairemo KJ; van Dongen GA
Oral Oncol; 2004 Sep; 40(8):761-72. PubMed ID: 15288829
[TBL] [Abstract][Full Text] [Related]
8. Immunoscintigraphy and radioimmunotherapy in Cuba: experiences with labeled monoclonal antibodies for cancer diagnosis and treatment (1993-2013).
Peña Y; Perera A; Batista JF
MEDICC Rev; 2014; 16(3-4):55-60. PubMed ID: 25208121
[TBL] [Abstract][Full Text] [Related]
9. Radiolabeling of antibodies for therapy and diagnosis.
Baranowska-Kortylewicz J; Dalrymple GV; Quadri SM; Harrison KA
Methods Mol Biol; 1995; 51():423-39. PubMed ID: 7581715
[No Abstract] [Full Text] [Related]
10. Principles of radioimmunotherapy for hematologists and oncologists.
Press OW; Rasey J
Semin Oncol; 2000 Dec; 27(6 Suppl 12):62-73. PubMed ID: 11226002
[TBL] [Abstract][Full Text] [Related]
11. Status of radiolabeled monoclonal antibodies for diagnosis and therapy of cancer.
Divgi CR
Oncology (Williston Park); 1996 Jun; 10(6):939-53; discussion 954, 957-8. PubMed ID: 8823804
[TBL] [Abstract][Full Text] [Related]
12. Radioimmunodiagnosis and therapy.
Verhaar-Langereis MJ; Zonnenberg BA; de Klerk JM; Blijham GH
Cancer Treat Rev; 2000 Feb; 26(1):3-10. PubMed ID: 10660488
[TBL] [Abstract][Full Text] [Related]
13. A new radiopharmaceutical compound (131I-PR81) for radioimmunotherapy of breast cancer: labeling of antibody and its quality control.
Mohammadnejad J; Rasaee MJ; Babaei MH; Paknejad M; Zahir MH; Salouti M; Rajabi AB; Mazidi M
Hum Antibodies; 2010; 19(4):79-88. PubMed ID: 21178279
[TBL] [Abstract][Full Text] [Related]
14. Pretargeting strategies for radio-immunoguided tumour localisation and therapy.
Stoldt HS; Aftab F; Chinol M; Paganelli G; Luca F; Testori A; Geraghty JG
Eur J Cancer; 1997 Feb; 33(2):186-92. PubMed ID: 9135486
[TBL] [Abstract][Full Text] [Related]
15. Immunoadsorption: an enhancement strategy for radioimmunotherapy.
DeNardo GL; Maddock SW; Sgouros G; Scheibe PO; DeNardo SJ
J Nucl Med; 1993 Jun; 34(6):1020-7. PubMed ID: 8509840
[No Abstract] [Full Text] [Related]
16. A model for others: a strategy for improving diagnosis and therapy of human malignancies using monoclonal antibodies targeting TAG-72 oncofetal antigen.
Larson SM
Cancer Invest; 1993; 11(2):235-8. PubMed ID: 8462025
[No Abstract] [Full Text] [Related]
17. The role of PAM4 in the management of pancreatic cancer: diagnosis, radioimmunodetection, and radioimmunotherapy.
Han S; Jin G; Wang L; Li M; He C; Guo X; Zhu Q
J Immunol Res; 2014; 2014():268479. PubMed ID: 24818166
[TBL] [Abstract][Full Text] [Related]
18. Animal models for radiolabeled monoclonal antibodies in cancer research.
Aas M; Fjeld JG
Acta Oncol; 1993; 32(7-8):819-24. PubMed ID: 8305231
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo evaluation of direct rhenium-188-labeled anti-CD52 monoclonal antibody alemtuzumab for radioimmunotherapy of B-cell chronic lymphocytic leukemia.
De Decker M; Bacher K; Thierens H; Slegers G; Dierckx RA; De Vos F
Nucl Med Biol; 2008 Jul; 35(5):599-604. PubMed ID: 18589304
[TBL] [Abstract][Full Text] [Related]
20. Two-step immunological approaches for imaging and therapy.
Rosebrough SF
Q J Nucl Med; 1996 Sep; 40(3):234-51. PubMed ID: 8961802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
